Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-21-059869

Chief Medical Officer acquired 74,520 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Eisner Mark Chief Medical Officer 2021-10-04 Grant or award +74,520 109,520 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Eisner Mark Chief Medical Officer 2021-10-04 Grant or award · Stock Option (Right to Buy) +44,520 44,520 D: show line 2 in the form
Loading xslF345X03/doc4.xml…